Research reveals IGFBP6’s role in suppressing vascular inflammation and atherosclerosis, suggesting it as a novel target for cardiovascular disease therapy.
Early Win for PTSD Drug; FDA OKs AI Sleep Diagnostic; Extreme Social Isolation Tool
ALTO-100, an investigational drug that works to restore plasticity in the brain, yielded a larger reduction in CAPS-5 scores in patients with biomarker-defined post-traumatic stress
September 28, 2023